UNH Research Finds
Venom of Cone Snail
Could Lead to Future
Diabetes Treatments
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THE CONE SHELL IS KNOWN FOR ITS SERENE MOTTLED COLORS BUT RESEARCHERS AT THE
UNIVERSITY OF NEW HAMPSHIRE FOUND VARIANTS OF THE VENOM SPEWED BY THE CONE
SNAIL LIVING INSIDE MAY OFFER POSSIBILITIES FOR DEVELOPING NEW FAST-ACTING DRUGS
TO HELP TREAT DIABETES. PHOTO CREDIT: WIKIMEDIA COMMONS

DURHAM, N.H.— The tapered cone shell is popular among seashell collectors for its
colorful patterns, but the smooth mottled shells are also home to the cone snail which is
capable of spewing a potent insulin-like venom that can paralyze its prey. Researchers
at the University of New Hampshire have found that variants of this venom, known as
cone snail insulin (Con-Ins), could offer future possibilities for developing new fastacting drugs to help treat diabetics.
“Diabetes is rising at an alarming rate and it’s become increasingly important to find new
alternatives for developing effective and budget-friendly drugs for patients suffering with
the disease,” said Harish Vashisth, associate professor of chemical engineering. “Our
work found that the modeled Con-Ins variants, or analogs, bind even better to receptors
in the body than the human hormone and may work faster which could make them a
favorable option for stabilizing blood sugar levels and a potential for new therapeutics.”
In their study, recently published in the journal Proteins: Structure, Function, and
Bioinformatics, researchers looked more closely at the cone snail venom which induces
a hypoglycemic reaction that lowers blood sugar levels. Unlike insulin made in the body,
the venom’s peptide sequence - which allows it to bind to human insulin receptors – is
much shorter. To test whether it would still bind effectively, the researchers used
sequences of the insulin-like peptides in the venom of the cone snail C. geographus as
a template to model six different Con-Ins analogs. The newly created variants were
made up of much shorter peptide chains than human insulin - lacking the last eight
residues of the B-chain of the human insulin.
To study the stability and variability of the new Con-Ins structures, they conducted
multiple independent computer simulations of each Con-Ins variant complex with human
insulin receptor in a near-physiological environment (accounting for water solvent,
salinity of solution, temperature and pressure). They found that each insulin complex
remained stable during the simulations and the designed peptides bound strongly –
even better than the naturally occurring human insulin hormone. The interactions were
then compared with the human insulin receptor and it was determined that each ConIns variant exhibits few feasible residue substitutions in human insulin.
“While more studies are needed, our research shows that despite the shorter peptide
sequences, the cone snail venom could be a viable substitute and we are hopeful it will
motivate future designs for new fast-acting drug options,” said Biswajit Gorai,
postdoctoral research associate and lead author.
The insulin-like venom released by certain cone snails can be highly dangerous causing
a hypoglycemic shock that immobilizes fish and potential prey. C. geographus has the
most toxic sting known among the species and there have been reports of human
fatalities, especially to unsuspected divers who are not aware of the snail’s venom.
Funding was provided by the National Institute of General Medical Sciences of the
National Institutes of Health under Award Number R35GM138217. The content is solely
the responsibility of the authors and does not necessarily represent the official views of
the National Institutes of Health.

The University of New Hampshire inspires innovation and transforms lives in our state,
nation, and world. More than 16,000 students from all 50 states and 71 countries
engage with an award-winning faculty in top-ranked programs in business, engineering,
law, health and human services, liberal arts and the sciences across more than 200
programs of study. As one of the nation’s highest-performing research universities, UNH
partners with NASA, NOAA, NSF and NIH, and receives more than $110 million in
competitive external funding every year to further explore and define the frontiers of
land, sea and space.
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